Roberto Ferrara

4PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 10, 2022
Eating away T cell responses in lung cancer.

Roberto Ferrara, Luca Roz

|Sep 01, 2022
Is hyperprogressive disease a specific phenomenom of immunotherapy?

Marta Brambilla, Giuseppe Lo Russo, Roberto Ferrara

|Jun 20, 2022
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy.

Emma Zattarin, Sara Manglaviti, Giulia Apollonio

|Jul 21, 2020
Atypical patterns of response and progression in the era of immunotherapy combinations.

Roberto Ferrara, Ignacio Matos

Pageof 1

Frequent Collaborators

1 joint publications

Emma Zattarin

1 joint publications

Achille Bottiglieri

1 joint publications

Giuseppe Lo Russo

1 joint publications

Arsela Prelaj